Pyridoxine restores endothelial cell function in high glucose.

Area of Science:

• Endothelial cell biology
• Vascular physiology
• Diabetic complications

Background:

• High glucose conditions impair endothelial cell function, affecting migration and response to shear stress.
• Advanced glycosylation end products contribute to endothelial dysfunction in diabetes.
• Aminoguanidine has shown potential in restoring endothelial cell alignment and elongation.

Purpose of the Study:

• To investigate if aminoguanidine can restore endothelial cell migratory ability.
• To determine if pyridoxine (vitamin B6) can restore endothelial cell migration and response to shear stress.
• To evaluate pyridoxine's efficacy in high glucose environments.

Main Methods:

• Human aortic endothelial cells cultured in varying glucose concentrations (5.5–30.5 mM).
• Treatment with aminoguanidine (5 mM) or pyridoxine (10–1,000 mg/L).
• Assessed cell migration via scrape wound assay and response to shear stress (10 dynes/cm²).

Main Results:

• Aminoguanidine fully restored migratory ability in high glucose.
• Pyridoxine (100 mg/L) partially restored migration in 30.5 mM glucose and fully restored it in 17.5 mM glucose.
• Pyridoxine (100 mg/L) fully restored endothelial cell alignment, elongation, and shear stress response in 30.5 mM glucose.

Conclusions:

• Pyridoxine, at safe dosages, effectively restores endothelial cell migration and shear stress response in high-glucose conditions.
• Pyridoxine demonstrates potential as a therapeutic agent for diabetic ulcers and atherosclerosis.
• Endothelial dysfunction in diabetes is linked to pathologies like diabetic ulcers and atherosclerosis, suggesting pyridoxine's therapeutic relevance.